Literature DB >> 17804126

A mutant of Mycobacterium tuberculosis lacking the 19-kDa lipoprotein Rv3763 is highly attenuated in vivo but retains potent vaccinogenic properties.

Marcela Henao-Tamayo1, Ana Paula Junqueira-Kipnis, Diane Ordway, Mercedes Gonzales-Juarrero, Graham R Stewart, Douglas B Young, Robert J Wilkinson, Randall J Basaraba, Ian M Orme.   

Abstract

A mutant of Mycobacterium tuberculosis (Delta 19) lacking the 19-kDa lipoprotein grows well in culture in vitro but was shown here to be essentially incapable of any significant replication in mice, even in mice lacking the gamma interferon gene. Despite this, mice inoculated with Delta 19 were equally protected against an aerosol delivered challenge with M. tuberculosis compared to the conventional BCG vaccine. Cellular responses, including the generation of activated CD4 and CD8 cells secreting gamma interferon, were produced in similar numbers, and lung cells, particularly dendritic macrophages, exhibited high levels of Class-II MHC expression. These data show that despite being highly attenuated, the Delta 19 mutant strongly retained vaccinogenic properties.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17804126      PMCID: PMC2180418          DOI: 10.1016/j.vaccine.2007.07.042

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  19 in total

Review 1.  Toll-like receptors: how they work and what they do.

Authors:  Bruce Beutler
Journal:  Curr Opin Hematol       Date:  2002-01       Impact factor: 3.284

Review 2.  Toll-like receptors: molecular mechanisms of the mammalian immune response.

Authors:  H D Brightbill; R L Modlin
Journal:  Immunology       Date:  2000-09       Impact factor: 7.397

Review 3.  How we detect microbes and respond to them: the Toll-like receptors and their transducers.

Authors:  B Beutler; K Hoebe; X Du; R J Ulevitch
Journal:  J Leukoc Biol       Date:  2003-07-01       Impact factor: 4.962

4.  Deletion of the 19kDa antigen does not alter the protective efficacy of BCG.

Authors:  V V Yeremeev; G R Stewart; O Neyrolles; K Skrabal; V G Avdienko; A S Apt; D B Young
Journal:  Tuber Lung Dis       Date:  2000

5.  Mycobacterium tuberculosis 19-kDa lipoprotein promotes neutrophil activation.

Authors:  C Neufert; R K Pai; E H Noss; M Berger; W H Boom; C V Harding
Journal:  J Immunol       Date:  2001-08-01       Impact factor: 5.422

6.  Induction of apoptosis and release of interleukin-1 beta by cell wall-associated 19-kDa lipoprotein during the course of mycobacterial infection.

Authors:  Antonio Ciaramella; Anna Cavone; Marilina B Santucci; Sanjay K Garg; Nunzia Sanarico; Marialuisa Bocchino; Domenico Galati; Angelo Martino; Giovanni Auricchio; Melania D'Orazio; Graham R Stewart; Olivier Neyrolles; Douglas B Young; Vittorio Colizzi; Maurizio Fraziano
Journal:  J Infect Dis       Date:  2004-08-11       Impact factor: 5.226

7.  The Mycobacterium tuberculosis 19-kilodalton lipoprotein inhibits gamma interferon-regulated HLA-DR and Fc gamma R1 on human macrophages through Toll-like receptor 2.

Authors:  Adam J Gehring; Roxana E Rojas; David H Canaday; David L Lakey; Clifford V Harding; W Henry Boom
Journal:  Infect Immun       Date:  2003-08       Impact factor: 3.441

Review 8.  TLRs: differential adapter utilization by toll-like receptors mediates TLR-specific patterns of gene expression.

Authors:  Stefanie N Vogel; Katherine A Fitzgerald; Matthew J Fenton
Journal:  Mol Interv       Date:  2003-12

9.  Inhibition of IFN-gamma-induced class II transactivator expression by a 19-kDa lipoprotein from Mycobacterium tuberculosis: a potential mechanism for immune evasion.

Authors:  Rish K Pai; Marilyn Convery; Thomas A Hamilton; W Henry Boom; Clifford V Harding
Journal:  J Immunol       Date:  2003-07-01       Impact factor: 5.422

Review 10.  Toll-like receptors: function and roles in lung disease.

Authors:  Subhendu Basu; Matthew J Fenton
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2004-05       Impact factor: 5.464

View more
  9 in total

Review 1.  Virulence factors of the Mycobacterium tuberculosis complex.

Authors:  Marina A Forrellad; Laura I Klepp; Andrea Gioffré; Julia Sabio y García; Hector R Morbidoni; María de la Paz Santangelo; Angel A Cataldi; Fabiana Bigi
Journal:  Virulence       Date:  2012-10-17       Impact factor: 5.882

Review 2.  The ins and outs of Mycobacterium tuberculosis protein export.

Authors:  Lauren S Ligon; Jennifer D Hayden; Miriam Braunstein
Journal:  Tuberculosis (Edinb)       Date:  2011-12-21       Impact factor: 3.131

3.  Characterization of the Protective Immune Responses Conferred by Recombinant BCG Overexpressing Components of Mycobacterium tuberculosis Sec Protein Export System.

Authors:  Annuurun Nisa; Claudio Counoupas; Rachel Pinto; Warwick J Britton; James A Triccas
Journal:  Vaccines (Basel)       Date:  2022-06-14

4.  Intranasal vaccination with messenger RNA as a new approach in gene therapy: use against tuberculosis.

Authors:  Julio C C Lorenzi; Ana P F Trombone; Carolina D Rocha; Luciana P Almeida; Ricardo L Lousada; Thiago Malardo; Isabela C Fontoura; Renata A M Rossetti; Ana F Gembre; Aristóbolo M Silva; Celio L Silva; Arlete A M Coelho-Castelo
Journal:  BMC Biotechnol       Date:  2010-10-20       Impact factor: 2.563

5.  Modulation of cell death by M. tuberculosis as a strategy for pathogen survival.

Authors:  Markos Abebe; Louise Kim; Graham Rook; Abraham Aseffa; Liya Wassie; Martha Zewdie; Alimuddin Zumla; Howard Engers; Peter Andersen; T Mark Doherty
Journal:  Clin Dev Immunol       Date:  2011-01-04

6.  Ample glycosylation in membrane and cell envelope proteins may explain the phenotypic diversity and virulence in the Mycobacterium tuberculosis complex.

Authors:  Alemayehu Godana Birhanu; Solomon Abebe Yimer; Shewit Kalayou; Tahira Riaz; Ephrem Debebe Zegeye; Carol Holm-Hansen; Gunnstein Norheim; Abraham Aseffa; Markos Abebe; Tone Tønjum
Journal:  Sci Rep       Date:  2019-02-27       Impact factor: 4.379

7.  Screening Mycobacterium tuberculosis Secreted Proteins Identifies Mpt64 as a Eukaryotic Membrane-Binding Bacterial Effector.

Authors:  Chelsea E Stamm; Breanna L Pasko; Sujittra Chaisavaneeyakorn; Luis H Franco; Vidhya R Nair; Bethany A Weigele; Neal M Alto; Michael U Shiloh
Journal:  mSphere       Date:  2019-06-05       Impact factor: 4.389

8.  The fbpA/sapM double knock out strain of Mycobacterium tuberculosis is highly attenuated and immunogenic in macrophages.

Authors:  Sankaralingam Saikolappan; Jaymie Estrella; Smitha J Sasindran; Arshad Khan; Lisa Y Armitige; Chinnaswamy Jagannath; Subramanian Dhandayuthapani
Journal:  PLoS One       Date:  2012-05-04       Impact factor: 3.240

9.  Lipoproteins of slow-growing Mycobacteria carry three fatty acids and are N-acylated by apolipoprotein N-acyltransferase BCG_2070c.

Authors:  Juliane K Brülle; Andreas Tschumi; Peter Sander
Journal:  BMC Microbiol       Date:  2013-10-05       Impact factor: 3.605

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.